retatrutide gallbladder adverse events trial diarrhea: why it happens and how to manage it Retatrutide, an experimental weight-loss drug,

Long-term effects of empagliflozin in patients with chronic kidney disease

Energy Balance Modulation: Investigated for its ability to reduce food intake, enhance thermogenesis, and improve glycemic control in animal models

Ongoing studies may soon impact regulatory approval and treatment guidelines

Nooms 2024 retrospective study on its GLP-1 Companion program highlights the benefits of this integrated approach

However, whether any GLP-1 RA can replicate the bone-sparing effects observed with liraglutide in common obesity - and whether such effects require intact MC4R signaling - remains unknown [6]

ACE inhibitors and ARBs ACE inhibitors and angiotensin receptor blockers (ARBs) are the cornerstone of treatment for DKD